DoJ Enlists Supporting Cast Against ‘Bad Actors’ On Supplement Stage
This article was originally published in The Tan Sheet
Executive Summary
DoJ explores broader action and new avenues to rid the supplement market of noncompliant firms, Deputy Assistant Attorney General Olin says at a FDLI conference. CFSAN Deputy Director Michael Roosevelt says identification of unknown supplement ingredients is a 2016 priority.